International Biochemical (U-IBCL) - News Release
IBCI Announces Meeting With Federal Agency Concerning Bio-terrorism Set For Monday, February 3, 2003
ATLANTA, Jan. 30 /PRNewswire/ -- International BioChemical Industries, Inc. (BULLETIN BOARD: IBCL) , formerly known as BioShield Technologies, Inc., announced that a Federal government agency, requesting urgency, has scheduled its meeting with IBCI to discuss test data and BioShield products that will be effective in the war on bio-terrorism. The discussion will include manufacturing capabilities, good laboratory practices and protocols, security of the facility and security of internal data files including test locations and employee confidentiality.
About International BioChemical Industries:
International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging growth company with the only antimicrobial technology approved by the EPA for residual kill on hard surfaces up to 28 days. Additional approvals by the EPA include 5 year residual kill in textiles, approval for use in cosmetics and approval for fogging. The company's antimicrobial technology is an alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria on contact and can remain active for extended time periods. To date IBCI has received four U.S. patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.
Further information on IBCI and its line of products can be found by visiting the firm's web site at bioshield.com , or by calling 1-770-925-3653, Tim Moses.
Safe Harbor/Forward-looking Statements:
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of IBCI; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. IBCI does not undertake to revise or update any forward- looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of IBCI.
International BioChemical Industries, Inc.
CONTACT: Tim Moses of International BioChemical Industries, Inc.,
+1-770-925-3653
Web site: bioshield.com |
